PMC:7381711 / 17090-17227 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T149","span":{"begin":39,"end":46},"obj":"Body_part"},{"id":"T150","span":{"begin":125,"end":132},"obj":"Body_part"}],"attributes":[{"id":"A149","pred":"fma_id","subj":"T149","obj":"http://purl.org/sig/ont/fma/fma82839"},{"id":"A150","pred":"fma_id","subj":"T150","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"A second, albeit rare, complication of heparin therapy is HIT, which is estimated to occur in 0.2–3% of patients who receive heparin (4)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"599","span":{"begin":104,"end":112},"obj":"Species"},{"id":"601","span":{"begin":39,"end":46},"obj":"Chemical"},{"id":"602","span":{"begin":125,"end":132},"obj":"Chemical"},{"id":"609","span":{"begin":58,"end":61},"obj":"Disease"}],"attributes":[{"id":"A599","pred":"tao:has_database_id","subj":"599","obj":"Tax:9606"},{"id":"A601","pred":"tao:has_database_id","subj":"601","obj":"MESH:D006493"},{"id":"A602","pred":"tao:has_database_id","subj":"602","obj":"MESH:D006493"},{"id":"A609","pred":"tao:has_database_id","subj":"609","obj":"MESH:D013921"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A second, albeit rare, complication of heparin therapy is HIT, which is estimated to occur in 0.2–3% of patients who receive heparin (4)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T145","span":{"begin":58,"end":61},"obj":"Disease"}],"attributes":[{"id":"A145","pred":"mondo_id","subj":"T145","obj":"http://purl.obolibrary.org/obo/MONDO_0018048"}],"text":"A second, albeit rare, complication of heparin therapy is HIT, which is estimated to occur in 0.2–3% of patients who receive heparin (4)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T115","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"A second, albeit rare, complication of heparin therapy is HIT, which is estimated to occur in 0.2–3% of patients who receive heparin (4)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T199","span":{"begin":39,"end":46},"obj":"Chemical"},{"id":"T200","span":{"begin":125,"end":132},"obj":"Chemical"}],"attributes":[{"id":"A199","pred":"chebi_id","subj":"T199","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A200","pred":"chebi_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"}],"text":"A second, albeit rare, complication of heparin therapy is HIT, which is estimated to occur in 0.2–3% of patients who receive heparin (4)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T104","span":{"begin":0,"end":137},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A second, albeit rare, complication of heparin therapy is HIT, which is estimated to occur in 0.2–3% of patients who receive heparin (4)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T39","span":{"begin":58,"end":61},"obj":"Phenotype"}],"attributes":[{"id":"A39","pred":"hp_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/HP_0011874"}],"text":"A second, albeit rare, complication of heparin therapy is HIT, which is estimated to occur in 0.2–3% of patients who receive heparin (4)."}

{"project":"2_test","denotations":[{"id":"32519894-28416511-2138204","span":{"begin":134,"end":135},"obj":"28416511"}],"text":"A second, albeit rare, complication of heparin therapy is HIT, which is estimated to occur in 0.2–3% of patients who receive heparin (4)."}